Fusen Pharmaceutical Company Limited (HKG:1652)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.020
+0.030 (3.03%)
Jun 22, 2026, 11:41 AM HKT

HKG:1652 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7325915911,0211,084943
Market Cap Growth
182.86%--42.05%-5.86%14.94%-73.09%
Enterprise Value
9779069641,2491,3511,059
Last Close Price
0.990.800.801.371.431.23
PE Ratio
-----46.17
PS Ratio
2.411.941.711.641.951.99
PB Ratio
1.841.491.511.651.571.17
P/TBV Ratio
1.991.611.631.711.561.17
P/FCF Ratio
9.167.407.64-11.07-
P/OCF Ratio
5.264.254.16-8.6816.09
EV/Sales Ratio
3.212.982.782.012.432.24
EV/EBITDA Ratio
19.5934.92-22.8916.5210.35
EV/EBIT Ratio
164.77--52.8726.3113.09
EV/FCF Ratio
12.2311.3412.45-13.79-
Debt / Equity Ratio
0.850.851.050.620.380.38
Debt / EBITDA Ratio
10.0710.07-6.092.932.79
Debt / FCF Ratio
4.264.265.34-2.69-
Net Debt / Equity Ratio
0.620.621.000.560.170.26
Net Debt / EBITDA Ratio
9.529.52-11.296.331.452.02
Net Debt / FCF Ratio
3.093.095.05-3.631.21-2.70
Asset Turnover
0.220.220.250.420.380.31
Inventory Turnover
0.890.890.911.732.111.48
Quick Ratio
0.330.330.330.500.610.70
Current Ratio
0.560.560.590.850.851.04
Return on Equity (ROE)
-3.25%-3.25%-40.58%-6.18%-5.46%2.53%
Return on Assets (ROA)
-0.46%-0.46%-3.25%1.00%2.19%3.32%
Return on Invested Capital (ROIC)
-1.57%-1.39%-8.34%2.69%5.88%6.72%
Return on Capital Employed (ROCE)
-2.40%-2.40%-14.50%3.20%7.20%8.80%
Earnings Yield
-1.79%-2.22%-33.97%-3.92%-3.61%2.17%
FCF Yield
10.92%13.51%13.09%-9.33%9.03%-8.12%
Dividend Yield
-----0.91%
Payout Ratio
-----49.90%
Buyback Yield / Dilution
0.09%0.09%1.60%0.53%1.85%2.51%
Total Shareholder Return
0.09%0.09%1.60%0.53%1.85%3.42%